Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
325 participants
OBSERVATIONAL
2015-05-31
2018-08-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Airway Microbiome of Patients With Protracted Bacterial Bronchitis
NCT07255430
Acute Upper Respiratory Tract Infection - When is Bacteria Involved?
NCT01580137
Microbiome Analysis of Skin and Airway Samples and Effect of Face Masks
NCT04894422
Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter
NCT00688610
Respiratory Tract Infections and Prescription Drugs in Children and in Pregnancy
NCT01109589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group (healthy)
Participants who do not suffer from acute or chronic airway infections
no intervention, compare URT microbiome healthy control group-chronic rhinosinusitis patients
CRS patients
Patients who suffer from chronic rhinosinusitis
no intervention, compare URT microbiome healthy control group-chronic rhinosinusitis patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention, compare URT microbiome healthy control group-chronic rhinosinusitis patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* no acute or chronic airway infections
* no cancer
* no autoimmune diseases
* pregnant women
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ethisch Comité, UZA
prof. dr. Olivier Vanderveken, MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Antwerp University Hospital
Edegem, Antwerp, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
De Boeck I, Wittouck S, Martens K, Claes J, Jorissen M, Steelant B, van den Broek MFL, Seys SF, Hellings PW, Vanderveken OM, Lebeer S. Anterior Nares Diversity and Pathobionts Represent Sinus Microbiome in Chronic Rhinosinusitis. mSphere. 2019 Nov 27;4(6):e00532-19. doi: 10.1128/mSphere.00532-19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B300201524257
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.